Simplifying Global Compliance
FDAnews Device Daily Bulletin
FDA Cites Calif. LapBand Clinic on Misleading Commercials, Billboards
Aug. 2, 2012
Los Angeles weight-loss surgery clinic Lap-Band VIP has received an FDA warning letter for misleading marketing claims. According to the June 25 letter, the clinic misbranded the LapBand device in two television commercials and two billboards by not revealing risk information or requirements to qualify for the LapBand surgery, the June 25 letter states. The letter was recently posted to the FDA website.
Devices & Diagnostics Letter
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing